Phentolamine Mesylate Ophthalmic Solution Provides Lasting Pupil Modulation and Improves Near Visual Acuity in Presbyopic Glaucoma Patients in a Randomized Phase 2b Clinical Trial

PURPOSE: Phentolamine mesylate ophthalmic solution (PMOS), applied to the eye topically, was shown previously to have beneficial effects in patients with dim light vision disturbances (DLD), including decreased pupil diameter (PD), improved best-corrected distance visual acuity (BCDVA), as well as l...

Descripción completa

Detalles Bibliográficos
Autores principales: Pepose, Jay S, Hartman, Paul J, DuBiner, Harvey B, Abrams, Marc A, Smyth-Medina, Robert J, Moroi, Sayoko E, Meyer, Alan R, Sooch, Mina P, Jaber, Reda M, Charizanis, Konstantinos, Klapman, Seth A, Amin, Arin T, Yousif, Jonah E, Lazar, Eliot S, Karpecki, Paul M, Slonim, Charles B, McDonald, Marguerite B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802916/
https://www.ncbi.nlm.nih.gov/pubmed/33447013
http://dx.doi.org/10.2147/OPTH.S278169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802916/
https://www.ncbi.nlm.nih.gov/pubmed/33447013
http://dx.doi.org/10.2147/OPTH.S278169

Ejemplares similares